BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 15519647)

  • 1. Silent non-alcoholic fatty liver disease-a clinical-histological study.
    Sorrentino P; Tarantino G; Conca P; Perrella A; Terracciano ML; Vecchione R; Gargiulo G; Gennarelli N; Lobello R
    J Hepatol; 2004 Nov; 41(5):751-7. PubMed ID: 15519647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
    Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
    Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL
    Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.
    Wong VW; Hui AY; Tsang SW; Chan JL; Wong GL; Chan AW; So WY; Cheng AY; Tong PC; Chan FK; Sung JJ; Chan HL
    Aliment Pharmacol Ther; 2006 Oct; 24(8):1215-22. PubMed ID: 17014580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic steatohepatitis in type 2 diabetes mellitus.
    Gupte P; Amarapurkar D; Agal S; Baijal R; Kulshrestha P; Pramanik S; Patel N; Madan A; Amarapurkar A; Hafeezunnisa
    J Gastroenterol Hepatol; 2004 Aug; 19(8):854-8. PubMed ID: 15242486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic histology in obese patients undergoing bariatric surgery.
    Machado M; Marques-Vidal P; Cortez-Pinto H
    J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients.
    Tiniakos DG
    Gastroenterol Clin Biol; 2009; 33(10-11):930-9. PubMed ID: 19646834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese.
    Wong VW; Chan HL; Hui AY; Chan KF; Liew CT; Chan FK; Sung JJ
    Aliment Pharmacol Ther; 2004 Jul; 20(1):45-9. PubMed ID: 15225170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis.
    Tsang SW; Ng WF; Wu BP; Chow DA; Li ET; Wong TC
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):116-21. PubMed ID: 16706822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for pure steatosis in alcoholic patients.
    Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
    Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis?
    Crespo J; Fernández-Gil P; Hernández-Guerra M; Cayón A; Mayorga M; Domínguez-Diez A; Fernández-Escalante JC; Pons-Romero F
    Obes Surg; 2001 Jun; 11(3):254-7. PubMed ID: 11433896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects.
    Vilar L; Oliveira CP; Faintuch J; Mello ES; Nogueira MA; Santos TE; Alves VA; Carrilho FJ
    Nutrition; 2008; 24(11-12):1097-102. PubMed ID: 18640006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
    Haukeland JW; Konopski Z; Linnestad P; Azimy S; Marit Løberg E; Haaland T; Birkeland K; Bjøro K
    Scand J Gastroenterol; 2005 Dec; 40(12):1469-77. PubMed ID: 16293559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Obesity: risk factor for steatohepatitis and hepatic fibrosis].
    Poniachik J; Mancilla C; Contreras J; Csendes A; Smok G; Cavada G; Rojas J; Oksenberg D; Burdiles P; Maluenda F; Díaz JC
    Rev Med Chil; 2002 Jul; 130(7):731-6. PubMed ID: 12235896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.